Home › Funds › RTW INVESTMENTS, LP › CGEM

RTW INVESTMENTS, LP position in CGEM

CULLINAN THERAPEUTICS INC · Health Care

RTW INVESTMENTS, LP reported holding 2,364,347 shares of CGEM (CULLINAN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$43.1M, representing 0.37% of its reported portfolio and ranking #47 among its reported holdings. RTW INVESTMENTS, LP has disclosed CGEM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)2.36M sh
Reported value held$43.05M
Portfolio Weight0.37%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's CGEM position evolved

RTW INVESTMENTS, LP first disclosed a stake in CGEM in Q2 2024 at 1,052,630 shares (US$18.4M). The position peaked in Q2 2026 at 2,364,347 shares, worth US$43.1M. Across 9 filings, RTW INVESTMENTS, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 2,364,347 shares valued at US$43.1M — an increase of 658,387 shares quarter over quarter.. Notable position changes include a 62% increase in Q3 2024 (shares fell 27% over the following quarter), a 39% increase in Q2 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.05M $18.36M New
Q3 2024 1.71M $28.56M Add
Q4 2024 1.71M $20.78M Hold
Q1 2025 1.71M $12.91M Hold
Q2 2025 1.71M $12.85M Hold
Q3 2025 1.71M $10.12M Hold
Q4 2025 1.71M $17.66M Hold
Q1 2026 1.71M $24.24M Hold
Q2 2026 2.36M $43.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGEM and 13F data

CGEM (CULLINAN THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CGEM — the largest reported positions include MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), BVF INC/IL (US$104.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGEM

All CGEM fund holders →

FAQ

How long has RTW INVESTMENTS, LP held CGEM?

RTW INVESTMENTS, LP has disclosed CGEM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is RTW INVESTMENTS, LP's current position in CGEM?

As of Q2 2026, RTW INVESTMENTS, LP holds 2.36M shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $43.05M, representing 0.37% of its reported portfolio and ranking #47.

Has RTW INVESTMENTS, LP been buying or selling CGEM?

In the latest 13F filing (Q2 2026), RTW INVESTMENTS, LP increased its position in CGEM. The position peaked in Q2 2026 at 2.36M shares.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.